Compare Hinge Health Inc. Class A Common Stock (HNGE) vs SAP SE (SAP) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Hinge Health Inc. Class A Common Stock vs SAP SE — how do they compare? Hinge Health Inc. Class A Common Stock trades at $103.99 (market cap $8.47B), while SAP SE trades at $222.91 (market cap $254.61B). The key difference: SAP SE is far larger — about 30.1× Hinge Health Inc. Class A Common Stock's market cap, and SAP SE pays a 1.33% dividend while Hinge Health Inc. Class A Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Hinge Health Inc. Class A Common Stock for 0 Days and SAP SE for 118 Days on average.
| HNGE | SAP | |
|---|---|---|
Market Cap | $8.47B | $254.61B |
Volume | 1,624,526 | 1,684,839 |
Sector | Health | Technology |
52-Week High | $105.14 | $280.46 |
52-Week Low | $31.17 | $146.38 |
Typical Hold Time | 0 Days | 118 Days |
Enterprise Value | $8.09B | $253.35B |
Dividend Yield | — | 1.33% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Hinge Health (HNGE) trades at $105.14, up 0.31% on the day and near its 52-week high. The stock shows strong analyst support with a 93.75% buy rating, though the current price exceeds the consensus target of $101.62. Recent earnings beat expectations in two of the last three quarters, with Q3 2026 results due November 2. Fundamentals indicate robust revenue growth projections from $588 million in 2025 to $720 million in 2026, alongside a shift to profitability, but valuation multiples like EV/EBITDA at 82.33 remain elevated.
The outlook is cautiously optimistic given projected profitability and expansion into migraine and GI care, but risks include high insider selling, competitive pressures, and the stock's premium valuation. Execution on growth targets and Q3 earnings will be critical for sustaining momentum.
SAP trades at $219.75, up 0.87% today, with a bullish technical signal from moving averages. The company reported strong revenue growth to $36.8B in 2025 and a net income margin of 20.41%. Recent earnings show a mix of beats and one miss, while analyst consensus is a Buy with a $253.60 price target. Cloud revenue growth of 24% in Q2 2026 and AI initiatives are key drivers, though competition and margin pressures from cloud transitions pose challenges.
The outlook for SAP is positive, supported by robust cloud adoption and AI integration, offering potential upside to the consensus target. Risks include execution on AI capabilities, competitive threats from new entrants, and macroeconomic sensitivity in software spending. The stock's valuation at a P/E of 29.48 requires sustained earnings growth to justify further gains.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Hinge Health Inc. Class A Common Stock
Hinge Health Inc. operates a digital musculoskeletal (MSK) care platform that delivers exercise therapy for joint and muscle conditions through health plans and employers. Its Precision Motion Technology combines wearable sensors and computer vision to guide patients through clinician-directed physical therapy remotely.
Read more on HNGE →About SAP SE
Founded in 1972 by former IBM employees, SAP provides database technology and enterprise resource planning software to enterprises around the world. Across more than 180 countries, the company serves 440,000 customers, approximately 80% of which are small to medium-size enterprises.
Read more on SAP →
